Aktiesnakken — November 2010
-
de skal finde på at bruge alle de penge på noget andet end arzerra ihvertfald
-
hvad var det gode tal for resterende milestones? kan i huske det
-
var det 600 mill dollars? der så skal halveres?
-
så 1, 8 milliard over de næste 9 år= 200 mill om året
-
en deal om året og genmab er cashflow positive
-
og så er der lundbeck dealen
-
nå nu må jeg til køjs
-
vi ses drenge
-
see
you -
-
god morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind